Hans J. W. de Haard
Corporate Officer/Principal bei University of Utrecht
Profil
Hans J. W. de Haard gründete argenx SE und AgomAb Therapeutics NV. Derzeit hat er die Position des Chief Scientific Officer bei argenx SE inne. Außerdem ist er Professor an der Universit de Franche-Comt und Professor-Camelid Immunologie an der Universität Utrecht. Zuvor war er Wissenschaftler bei Unilever NV und Director-Technology Development bei Ablynx NV. Dr. De Haard hat an der Universität Maastricht promoviert und einen Hochschulabschluss erworben.
Aktive Positionen von Hans J. W. de Haard
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Utrecht | Corporate Officer/Principal | - |
| Université de Franche-Comté | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Hans J. W. de Haard
| Unternehmen | Position | Ende |
|---|---|---|
AgomAb Therapeutics NV
 AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Founder | - |
| ARGENX SE | Founder | - |
| UNILEVER N.V. | Chief Tech/Sci/R&D Officer | - |
| ABLYNX | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Hans J. W. de Haard
| Maastricht University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Unilever NV
 Unilever NV Food DistributorsDistribution Services Unilever NV engages in the production and marketing of consumer goods in the nutrition, hygiene, and personal care categories. It operates through the following segments: Beauty and Personal Care, Foods and Refreshment, and Home Care. The Beauty and Personal Care segment covers the sales of skin and hair care products, deodorants and oral care products. The Foods and Refreshment segment includes the sales of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads. The Home Care segment is in charge of the sales of home care products such as powders, liquids and capsules, soap bars, and a wide range of cleaning products. The company was founded on November 9, 1927 and is headquartered in Rotterdam, Netherlands. | Distribution Services |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |
